vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Veritone, Inc. (VERI). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $26.6M, roughly 1.5× Veritone, Inc.). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -109.8%, a 83.8% gap on every dollar of revenue. On growth, Veritone, Inc. posted the faster year-over-year revenue change (21.1% vs -23.3%). PETMED EXPRESS INC produced more free cash flow last quarter ($-9.2M vs $-17.1M). Over the past eight quarters, Veritone, Inc.'s revenue compounded faster (39.0% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Veritone, Inc. is an American artificial intelligence technology company based in Irvine, California founded in 2014. It serves a variety of industries including media, professional sports teams, federal government agencies, energy utilities, and state and local police departments.

PETS vs VERI — Head-to-Head

Bigger by revenue
PETS
PETS
1.5× larger
PETS
$40.7M
$26.6M
VERI
Growing faster (revenue YoY)
VERI
VERI
+44.4% gap
VERI
21.1%
-23.3%
PETS
Higher net margin
PETS
PETS
83.8% more per $
PETS
-26.0%
-109.8%
VERI
More free cash flow
PETS
PETS
$7.9M more FCF
PETS
$-9.2M
$-17.1M
VERI
Faster 2-yr revenue CAGR
VERI
VERI
Annualised
VERI
39.0%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
PETS
PETS
VERI
VERI
Revenue
$40.7M
$26.6M
Net Profit
$-10.6M
$-29.2M
Gross Margin
23.3%
Operating Margin
-25.7%
-68.2%
Net Margin
-26.0%
-109.8%
Revenue YoY
-23.3%
21.1%
Net Profit YoY
-1392.6%
-34.5%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
VERI
VERI
Q4 25
$40.7M
Q3 25
$44.4M
$26.6M
Q2 25
$51.2M
$23.2M
Q1 25
$50.8M
$22.5M
Q4 24
$52.0M
$22.4M
Q3 24
$58.0M
$22.0M
Q2 24
$66.2M
$24.1M
Q1 24
$65.1M
$24.2M
Net Profit
PETS
PETS
VERI
VERI
Q4 25
$-10.6M
Q3 25
$-8.5M
$-29.2M
Q2 25
$-34.2M
$-26.5M
Q1 25
$-11.6M
$-19.9M
Q4 24
$-707.0K
$31.8M
Q3 24
$2.3M
$-21.7M
Q2 24
$3.8M
$-22.2M
Q1 24
$-5.0M
$-25.2M
Gross Margin
PETS
PETS
VERI
VERI
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
72.6%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
71.2%
Q2 24
28.8%
72.6%
Q1 24
29.3%
70.8%
Operating Margin
PETS
PETS
VERI
VERI
Q4 25
-25.7%
Q3 25
-18.9%
-68.2%
Q2 25
-66.7%
-82.0%
Q1 25
-11.9%
-96.3%
Q4 24
-0.9%
-93.8%
Q3 24
1.0%
-102.3%
Q2 24
6.6%
-84.4%
Q1 24
-5.9%
-100.9%
Net Margin
PETS
PETS
VERI
VERI
Q4 25
-26.0%
Q3 25
-19.2%
-109.8%
Q2 25
-66.7%
-114.2%
Q1 25
-22.9%
-88.5%
Q4 24
-1.4%
141.7%
Q3 24
4.0%
-98.9%
Q2 24
5.7%
-92.4%
Q1 24
-7.7%
-104.3%
EPS (diluted)
PETS
PETS
VERI
VERI
Q4 25
$-0.50
Q3 25
$-0.41
Q2 25
$-1.65
$-0.53
Q1 25
$-0.56
$-0.41
Q4 24
$-0.03
$0.85
Q3 24
$0.11
$-0.57
Q2 24
$0.18
$-0.59
Q1 24
$-0.24
$-0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
VERI
VERI
Cash + ST InvestmentsLiquidity on hand
$26.9M
$36.2M
Total DebtLower is stronger
$35.4M
Stockholders' EquityBook value
$32.8M
$15.5M
Total Assets
$88.0M
$198.6M
Debt / EquityLower = less leverage
2.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
VERI
VERI
Q4 25
$26.9M
Q3 25
$36.1M
$36.2M
Q2 25
$41.1M
$13.6M
Q1 25
$54.7M
$16.1M
Q4 24
$50.1M
$16.9M
Q3 24
$52.0M
$11.4M
Q2 24
$46.0M
$46.0M
Q1 24
$55.3M
$90.7M
Total Debt
PETS
PETS
VERI
VERI
Q4 25
Q3 25
$35.4M
Q2 25
$37.3M
Q1 25
$39.2M
Q4 24
$41.2M
Q3 24
$73.6M
Q2 24
$75.6M
Q1 24
$77.5M
Stockholders' Equity
PETS
PETS
VERI
VERI
Q4 25
$32.8M
Q3 25
$43.1M
$15.5M
Q2 25
$51.5M
$3.5M
Q1 25
$85.1M
$14.8M
Q4 24
$96.2M
$13.5M
Q3 24
$96.4M
$-25.2M
Q2 24
$93.5M
$-5.7M
Q1 24
$96.7M
$14.9M
Total Assets
PETS
PETS
VERI
VERI
Q4 25
$88.0M
Q3 25
$100.3M
$198.6M
Q2 25
$109.8M
$188.1M
Q1 25
$148.7M
$199.6M
Q4 24
$144.8M
$198.1M
Q3 24
$146.0M
$336.4M
Q2 24
$152.7M
$321.8M
Q1 24
$169.9M
$359.6M
Debt / Equity
PETS
PETS
VERI
VERI
Q4 25
Q3 25
2.28×
Q2 25
10.71×
Q1 25
2.66×
Q4 24
3.06×
Q3 24
Q2 24
Q1 24
5.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
VERI
VERI
Operating Cash FlowLast quarter
$-9.2M
$-15.9M
Free Cash FlowOCF − Capex
$-9.2M
$-17.1M
FCF MarginFCF / Revenue
-22.7%
-64.2%
Capex IntensityCapex / Revenue
0.1%
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-46.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
VERI
VERI
Q4 25
$-9.2M
Q3 25
$-2.2M
$-15.9M
Q2 25
$-12.3M
$-8.2M
Q1 25
$7.0M
$-17.0M
Q4 24
$-1.2M
$-500.0K
Q3 24
$7.4M
$3.6M
Q2 24
$-8.5M
$-42.7M
Q1 24
$7.1M
$14.9M
Free Cash Flow
PETS
PETS
VERI
VERI
Q4 25
$-9.2M
Q3 25
$-4.8M
$-17.1M
Q2 25
$-13.6M
$-9.2M
Q1 25
$4.6M
$-18.4M
Q4 24
$-1.9M
$-1.7M
Q3 24
$6.1M
$1.9M
Q2 24
$-9.2M
$-44.1M
Q1 24
$5.9M
$13.1M
FCF Margin
PETS
PETS
VERI
VERI
Q4 25
-22.7%
Q3 25
-10.8%
-64.2%
Q2 25
-26.5%
-39.6%
Q1 25
9.1%
-81.9%
Q4 24
-3.7%
-7.4%
Q3 24
10.6%
8.6%
Q2 24
-13.9%
-183.4%
Q1 24
9.0%
54.2%
Capex Intensity
PETS
PETS
VERI
VERI
Q4 25
0.1%
Q3 25
5.9%
4.6%
Q2 25
2.5%
4.1%
Q1 25
4.7%
6.0%
Q4 24
1.5%
5.2%
Q3 24
2.2%
7.7%
Q2 24
1.0%
5.9%
Q1 24
1.9%
7.6%
Cash Conversion
PETS
PETS
VERI
VERI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.02×
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

VERI
VERI

Software Products And Services$20.9M78%
Other$2.3M9%
Public Sector$2.0M7%
Representation Services$1.5M6%

Related Comparisons